Gines Diego Miralles - 18 Jul 2024 Form 3 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Role
Director
Signature
/s/ Jennifer Bush, Attorney-in-Fact
Issuer symbol
ARTV
Transactions as of
18 Jul 2024
Net transactions value
$0
Form type
3
Filing time
18 Jul 2024, 20:06:41 UTC
Next filing
17 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ARTV Director Stock Option (right to buy) 18 Jul 2024 Common Stock 12,995 $5.18 Direct
holding ARTV Director Stock Option (right to buy) 18 Jul 2024 Common Stock 12,995 $5.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting is monthly over a 6-month period starting May 1, 2024 in equal monthly amounts.